Brooke Cohen leverages her background in chemical and biomedical engineering to assist clients in a wide variety of technologies.
Brooke’s practice focuses on patent prosecution and counseling. She is experienced prosecuting patents for medical devices, medical imaging technologies, artificial intelligence in the life sciences field, software, chemicals, and mechanical systems. Brooke has also counseled clients for IP transactions, product clearance and non-infringement.
- "Legal Profession, Professional Perspective - Best Practices for Working With Paralegals," co-author, Bloomberg Law, August 2023.
- "Attorney Development Throughout Your Career," co-author, Bloomberg Law, June 9, 2023.
- "Rainmaker Skills for a Junior Associate,” co-author, Bloomberg Law, January 25, 2023.
- "How To Navigate Patent Eligibility Of AI-Driven Diagnostics," co-author, Med Device Online, July 28, 2022.
- "How Business Development Can Help You," co-author, Bloomberg Law, July 2022.
- "What Attorney Development Can Do For You," co-author, Bloomberg Law, July 2022.
- "How to Navigate the Patenting Challenges of AI-Assisted Drug Discovery," co-author, Pharmaceutical Online, June 17, 2022.
- "Terminating an IPR: File Your Settlement Agreements Without Concern-At Least For Now," co-author, IP Watchdog, April 19, 2022.
J.D., The University of Texas School of Law, 2021
M.E., Biomedical Engineering, Texas A&M University, 2018
B.S., Chemical and Biomolecular Engineering, Cornell University, 2017, cum laude
Intern to the Honorable Judge Lee Yeakel, United States District Court, Western District of Texas, 2020
U.S. Patent and Trademark Office
Haynes and Boone, LLP Lawyers David McCombs, Eugene Goryunov, Brooke Cohen and Dina Blikshteyn authored an article in Law360 on the U.S. Supreme Court’s decision in Amgen Inc. v. Sanofi that further clarified the patent enablement requirement. Read an excerpt below: In Amgen Inc. v. Sanofi, the U.S. Supreme Court in May further clarified the patent enablement requirement. At issue in the case were [...]